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Abstract
Background: Bacterial vaginosis (BV) is a polymicrobial, superficial vaginal infection involving a reduction in the amount of
hydrogen peroxide-producing Lactobacillus and overgrowth of anaerobic bacteria. Common symptoms include increased fishy
smelling vaginal discharge which is usually white or gray in color. Burning with urination may occur and itching is uncommon. Risk
factors include douching, new or multiple sex partners, antibiotics, and use of intrauterine device among others.
Materials and Methods: This cross-sectional study assessed the prevalence of bacterial vaginosis among sexually active women
aged 15-45 years. Vaginal swabs were obtained with the use of sterile swab sticks which were later smeared on clean glass slides and
then Gram stained. The stained smears were observed for bacterial morphotypes with the X100 oil immersion objective and the
Nugent scoring system was used to determine BV. Data were analyzed using the Statistical Package for Social Scientists (SPSS)
version 17.0 and were considered significant at p ≤ 0.05. 
Results: A total of 100 women participated in the study with the overall prevalence of BV rated 38%. The prevalence of BV with
respect to associated factors was also investigated and it was observed that BV was more prevalent in the age groups 20-25 (48.1%)
and 25-29 (44.4%), those who had attained only primary education (60.5%), married women, (68.4%), pregnant women (71.0%),
and women who practiced vaginal douching, (97.4%). However, no statistical significant difference was observed in the prevalence
between these parameters (P > 0.05).
Conclusions: Conclusively, the prevalence of bacterial vaginosis in our study population is 38% and highest among women aged
between 25 and 34 years, pregnant women, married women, less educated women and women who practiced poor vaginal hygiene.
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Introduction
Reproductive-tract infections (RTI) including bacterial vaginosis, are major public health concerns among sexually–active
women in developing countries with bacterial vaginosis alone being responsible for 40-50% of vaginal infections (Spiegel, 1991).
Bacterial vaginosis (BV) is a polymicrobial, superficial vaginal infection involving a reduction in the amount of hydrogen peroxide-
producing Lactobacillus and overgrowth of anaerobic bacteria. The reduced numbers of Lactobacillus allow overgrowth of
anaerobic bacteria, especially Mycoplasma hominis, Bacteroides species, Mobiluncus species and Gardnerella vaginalis. Although
most of these organisms are present in small number in the normal vagina, Mobiluncus species are rarely found and indicates a
sensitive marker for the diagnosis of BV. However, recent studies suggests that G. vaginalis is the key player in the pathogenesis of
BV initiating the development of a biofilm and then becomes the scaffolding to which other species adhere (Verstraelen et al., 2013).
Past studies on the microbiota of the epithelial surfaces of vaginal biopsy from women with BV showed that G. vaginalis comprised
90% of the bacteria in the biofilm (Swidsinski et al., 2005).
Bacterial vaginosis is an extremely prevalent condition and the number one cause of vaginitis among sexually active
women (Yudin and Money, 2008). Although it is not a reportable disease, available data show the prevalence of BV among non-
pregnant women to range from 15% to 30% and 50% for pregnant women (Fleury et al., 1981; Shayo et al., 2012). However, the
majority of cases of BV are asymptomatic and remain unreported and untreated (Amsel et al., 1983). Fifty to 75 percent of women
with bacterial vaginosis (BV) are asymptomatic. Symptomatic women typically present with vaginal discharge and/or vaginal odor.
The discharge is off-white, thin, and homogeneous; the odor is an unpleasant "fishy smell" that may be more noticeable after sexual
intercourse and during menses.
Previously considered a benign condition, BV has been implicated in many gynecologic conditions and complications of
pregnancy including pelvic inflammatory disease, post hysterectomy vaginal cuff cellulites, endometriosis, amniotic fluid infection,
preterm delivery, preterm labor, premature rupture of the membranes, and possibly spontaneous abortions (Eschenback et al., 1988).
A cross sectional study carried out in Bangladesh reported that reproductive tract infections (RTI), including bacterial vaginosis, are
a major public-health problem among sexually active women. Among RTI investigated, bacterial vaginosis was responsible for 40 -
50% of vaginal infections in sexually –active women (Spiegel, 1991).
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Bacterial vaginosis (BV) resolves spontaneously in up to one-third of non-pregnant and one-half of pregnant women
(Klebanoff et al., 2004). Treatment is indicated for relief of symptoms in women with symptomatic infection and to prevent
postoperative infection in those with symptomatic and asymptomatic infection prior to abortion or hysterectomy or any post vaginal
surgical procedure. Treatment of BV may also reduce the risk of acquiring sexually transmitted diseases (STDs), including human
immunodeficiency virus (HIV) (Schwebke et al., 2004). For this reason, some experts support the concept of treating all women with
BV regardless of presence or absence of symptoms.
Risk factors for BV include sexual activity, new or multiple sexual partners and early age of sexual intercourse.
Epidemiologic studies are strongly supportive of sexual transmission of BV pathogens and most experts believe that BV does not
occur in women who have never had vaginal intercourse (Yen et al., 2003). However, BV can develop in women who have never
had sexual intercourse, probably because of other factors that may destabilize the normal vaginal flora such as douching and wearing
of tight fitting underwear (Papanikolaou et al., 2002; Fethers et al., 2009). Distortion of the vaginal flora may also result from sexual
activity alone without necessary transmission of the BV pathogens to susceptible sexual partners (Holzman et al., 2001). Generally,
the use of an intrauterine contraceptive device, douching, wearing of tight fitting underwear and personal hygiene are reported as risk
factors for BV (Chiaffarino et al., 2004; Klebanoff, 2010). Infection seems to be most common around the time of menstruation.
There is a high occurrence of BV and concordance of flora in women who have sex with women, further suggesting sexual
transmission is important. It is not clear, however, whether one type of sexual activity may be more important in the pathogenesis of
infection than another. As an example, oral-genital sex may be a more important risk factor than penile intromission into the vagina.
Although some degree of genetic susceptibility to BV is likely, no association between a gene polymorphism and BV has been
established.
Bacterial vaginosis is a risk factor for acquisition of herpes simplex virus type 2 (HSV-2), gonorrhea, and chlamydial
infection (Cherpes et al., 2003). The incidence of BV has also been associated with a greater occurrence of other sexually
transmitted infections like HIV and cytomegalovirus (Joesoef et al., 1995).
Materials and Methods
Ethics Statement
The study was approved by the Institutional Review Board of Saint Monica University Buea, Cameroon while
administrative authorization to collect clinical samples was obtained from the CDC Central Clinic, Tiko, where the study was
conducted. Written informed assent was obtained from the patients and data was treated with discrete confidentiality.
Study Population
The study population was drawn from the population of women attending the CDC Central Clinic, Tiko, South West of
Cameroon from January to June 2014. A total of 100 sexually active women aged from 15 to 45 years, who met the inclusion criteria
were recruited in this study. After detailed explanation of the study objectives and protocols by the researcher, the women gave their
consent to participate in the study by signing informed consent forms. Sexually active women who refused to give their consent or
who were menstruating at the time of recruitment were excluded from the study.
Socio-demographic Data
A structured questionnaire was used to collect participants’ socio-demographic data. Taken into consideration were the
participant’s age, marital status, pregnancy, knowledge of BV, clinical data, and other variables.
Samples
The samples analyzed were vaginal swabs and were collected aseptically from the women with the use of sterile swab
sticks. The participant was instructed to lie on the collection bed in a supine position. With both legs flexed, the labial majora was
held apart by the participant. A labeled sterile swab was carefully inserted into the vagina and discharge was collected by gently
rolling the inserted swab. The swab sticks were recapped and refrigerated (at 4ºC) for further processing at the end of each day.
Diagnosis of Bacterial Vaginosis
The Nugent criteria for the diagnosis of BV were employed (Nugent et al., 1991). According to this method, three bacterial
morphotypes – Lactobacillus, Mobiluncus and Gardnerella were used as markers of BV. Vaginal swabs were used to prepare smears
on clean, grease-free slides. The smears were allowed to air-dry and then fixed with 95% alcohol. The smears were then Gram
stained using the Jenson’s modified Gram technique as described by Cheesbrough (2006). The Gram stained smears were observed
under the light microscope (Olympus) using the oil immersion objective (x100). Lactobacillus morphotypes were reported as large
Gram positive bacilli, Mobiluncus as curved Gram negative or Gram variable rods while Gardneralla were reported as small Gram
variable bacilli. Using the Nugent scoring technique, scores ranged from 0 to 4 for Lactobacillus; 0 indicating that ≥ 30 organisms 
were found and 4 indicated that no organisms were found. In contrast, for Gardnerella, a score of 0 indicated that no organisms were
found and 4 indicated ≥ 30 organisms. For Mobiluncus, scores ranged from 0 to 2; 0 indicating no organisms and 2 indicating ≥ 5 
organisms. A total numerical score was calculated (ranging from 0 to 10) for each sample by summing the scores for each of the
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three morphotypes. The scores were classified into one of three ranges to define a case of BV; a score in the range 0-3 indicated
normal vaginal flora, 4-6 indicated altered vaginal flora which is not consistent with BV, and 7-10 was consistent with BV.
Data Analysis
Data obtained from this study was entered into the computer Microsoft Excel and analyzed using SPSS version 17.0. The




Participants’ socio-demographic data are presented in Table 1. Of the 100 participants, 54 (54%) were equally distributed
between the age ranges 25-29 and 30-34 years while only a few fell in the age ranges of 15-19 years (5%) and 40 years or more
(6%). More married women participated in the study (62%) as well as pregnant women (59%). With regards to educational level,
55% of the participants had attained only primary qualification and only one had never been to school.









Marital Status Married 62
Single 38
Education




Post high school 6
Pregnancy status Pregnant 59
Not pregnant 41
Participants’ Knowledge of Bacterial Vaginosis and Practices that Pre-dispose them to the Infection
Information concerning participants’ knowledge of BV as well as the practices they indulge in that could predispose them
to the infection is summarized in Table 2; only 38% of the participants had adequate knowledge of bacterial vaginosis and up to 97%
of them indulged in at least one practice that predisposes the infection.
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Table 2: Participants’ knowledge of BV and practices that predispose them to the infection
Assessed Variable Number of Respondents/100 Total
Yes No
Knowledge of urogenital tract infection 38 62 100
Knowledge of bacterial vaginosis 38 62 100
Knowledge of BV transmission 44 56 100
Knowledge of vaginal douching 32 68 100
Knowledge of risk associated with vaginal douching 40 60 100
Practicing vaginal douching 97 3 100
Use of antiseptics in vaginal douching 43 57 100
donning air-tight pants 33 67 100
Prevalence of Bacterial Vaginosis
Of the 100 participants, 38 were positive for bacterial vaginosis, 34 had alteration in vaginal normal flora that was not
consistent with BV while 28 were negative giving a prevalence rate of 38%. The prevalence of BV with respect to the various
sociodemographic data and patients’ characteristics is presented in Table 3. Although the prevalence of BV was higher in some
groups than others, no statistically significant differences were found (P-values ≥ 0.05).  









15-19 5 2 2 1 (20) χ=9.735 
P=0.46420-24 14 4 6 4 (28.5)
25-29 27 5 9 13 (48.1)
30-34 27 7 8 12 (44.4)
≥ 35 27 10 9 8 (29.6)
Level of education Uneducated 1 0 0 1 (100) χ=4.562 
P=0..803Primary 55 13 19 23 (41.8)
Secondary 24 9 7 8 (33.3)
High school 14 4 5 5 (35.7)
Post high school 6 2 3 1 (16.6)
Knowledge of BV
and its spread
Adequate 38 12 14 12 (31.6) χ=3.175 
P=0.529Inadequate 62 16 20 26 (41.9)
Marital status Married 62 17 19 26 (41.9) χ=1.225 
P=0.542Single 38 11 15 12 (31.6)
Pregnancy Pregnant 59 15 17 27 (45.8) χ=3.762 
P=0.152Non-pregnant 41 13 17 11 (26.8)
Practice vaginal
douching
Yes 97 25 35 37 (38.1) χ=5.615 
P=0.06No 3 2 0 1 (33.3)
Donne air-tight
pants
Yes 33 8 10 15 (45.5) χ=1.167 
P=0.558No 67 20 24 23 (34.3)
Clinical data of BV/Complications of BV
From the data obtained, 78% participants had current or past history of bacterial vaginosis or its complications ranging
from normal vaginal itches (40%), through children born with low weight (8%) to miscarriages (30%).




This study reported a prevalence of 38% for bacterial vaginosis among sexually active women in the study area. This
finding is comparable to that of Spiegel (1991) in Bangledesh showing a 40-50% prevalence rate for BV. Although little or no
information is available in Cameroon on bacterial vaginosis, this condition remains a major public-health problem among sexually
active women in Cameroon based on our findings. This problem is made worst in pregnant women due to its sequallae and adverse
effects on pregnancy and pregnancy outcome. The impact of bacterial vaginosis in pregnancy for the causation of premature rupture
of membranes, preterm delivery and low birth weight is well established (Koumans et al., 2001). Bacterial vaginosis is often
asymptomatic, and its diagnosis is inexpensive yet needs technical skill. Failure to detect BV early constitutes a major risk factor for
the acquisition of other sexually transmitted infections as previously reported (Joesoef et al., 1995; Cherpes et al., 2003).
We reported a higher prevalence of bacterial vaginosis among participants who attained only primary education or no
education at all, those who practiced vaginal douching and those who wore tight underwear. These findings raise the need for public
awareness and education on vaginal infections in general. Emphasis should be laid on proper hygienic practices as well as the bad
sides of early sex, multiple sex partners, change of sex partners, use of unprescribed drugs and antiseptics amongst others.
The higher prevalence of BV among pregnant women and married women remains a major phobia. Implementation of
diagnosis of BV during antenatal care especially during the second and third trimesters of pregnancy can ameliorate the condition by
reducing the number or frequency of BV-associated reproductive tract infections and birth defects. However, given the complicated
nature of BV diagnosis and considering the generally higher prevalence of BV among pregnant women, syndromic treatment may be
an alternative. We suggest that all married women should be screened at least once a year for BV so that positive cases can be
detected and treated early enough to reduce subsequent sequellae.
We, therefore, conclude that the prevalence of bacterial vaginosis in our study population is 38% and highest among
women aged between 25 and 34 years, pregnant women, married women, less educated women and women who practiced poor
vaginal hygiene.
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